[1] |
Wang SH, Chen XY, Wang XP. Jidong restless legs syndrome cohort study: objectives, design, and baseline screening[J]. Front Neurol, 2021, 12: 682448.
doi: 10.3389/fneur.2021.682448
URL
|
[2] |
杨任民, 陈卫东, 于同乐, 等. 癌症并发不宁腿综合征二例[J]. 安徽医学院学报, 1981, 16(03): 89-91.
|
[3] |
Filosa J, Omland PM, Hagen K, et al. Validation of questionnaires for restless legs syndrome in the general population: the Trøndelag Health Study(HUNT)[J]. J Sleep Res, 2022, 31(5): e13571.
doi: 10.1111/jsr.v31.5
URL
|
[4] |
Ando T, Goto Y, Mano K. Upper back restlessness: two case reports[J]. J Neurol Sci, 2016, 365: 137-138.
doi: 10.1016/j.jns.2016.04.019
pmid: 27206891
|
[5] |
Earley CJ, Jones BC, Ferré S. Brain-iron deficiency models of restless legs syndrome[J]. Exp Neurol, 2022, 356: 114158.
doi: 10.1016/j.expneurol.2022.114158
URL
|
[6] |
Liu HM, Chu M, Liu CF, et al. Analysis of serum vitamin D level and related factors in patients with restless legs syndrome[J]. Front Neurol, 2021, 12: 782565.
doi: 10.3389/fneur.2021.782565
URL
|
[7] |
Antelmi E, Coccagna G, Ferini-Strambi L, et al. ‘Restless bladder’ and the boundaries of the restless legs syndrome[J]. Eur J Neurol, 2013, 20(11): e128.
|
[8] |
Aquino CC, Mestre T, Lang AE. Restless genital syndrome in Parkinson disease[J]. JAMA Neurol, 2014, 71(12): 1559-1561.
doi: 10.1001/jamaneurol.2014.1326
pmid: 25285600
|
[9] |
马建芳, 陈生弟. 腹型不宁腿综合征二例[J]. 中华神经科杂志, 2014, 47(1): 68-69.
|
[10] |
梅俊华, 龚雪, 刘敏珍, 等. 三例以腹部症状为主的不安腿综合征患者临床特点分析[J]. 中华神经医学杂志, 2019, 18(10): 1031-1034.
|
[11] |
Guo S, Huang J, Jiang H, et al. Restless legs syndrome: from pathophysiology to clinical diagnosis and management[J]. Front Aging Neurosci, 2017, 9: 171.
doi: 10.3389/fnagi.2017.00171
pmid: 28626420
|
[12] |
Lv Q, Wang X, Asakawa T, et al. Pharmacologic treatment of restless legs syndrome[J]. Curr Neuropharmacol, 2021, 19(3): 372-382.
doi: 10.2174/1570159X19666201230150127
pmid: 33380302
|
[13] |
Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—history, rationale, description, and significance[J]. Sleep Med, 2014, 15(8): 860-873.
doi: 10.1016/j.sleep.2014.03.025
URL
|
[14] |
Taximaimaiti R, Luo X, Wang XP. Pharmacological and non-pharmacological treatments of sleep disorders in Parkinson’s disease[J]. Curr Neuropharmacol, 2021, 19(12): 2233-2249.
doi: 10.2174/1570159X19666210517115706
pmid: 33998990
|
[15] |
Trenkwalder C, Allen R, Högl B, et al. Comorbidities, treatment, and pathophysiology in restless legs syndrome[J]. Lancet Neurol, 2018, 17(11): 994-1005.
doi: S1474-4422(18)30311-9
pmid: 30244828
|